KalVista Pharmaceuticals (KALV) Form 144 Filed on May 27

AI Summary

KalVista Pharmaceuticals (KALV) filed Form 144 on May 27. This form is typically utilized for the sale of restricted and control securities. Filings like these can indicate insider selling activity, potentially impacting market sentiment. However, the exact volume or details of the securities sold were not disclosed in the article. Observers often look for such filings as they may reflect insider confidence or concerns regarding future performance.